Kura Oncology
OrganizationHeard in 3 episodes across 3 shows since Dec 2025
Kura Oncology, Inc. is a biopharmaceutical company developing precision medicines for cancer, including therapies targeting genetically defined tumors.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 1 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
| Nov 2026 | 2 |
Email alert
Email me when Kura Oncology comes up on a podcast
One email a week at most, with the new episodes that mention Kura Oncology. Free, no account needed, unsubscribe in one click.
What experts have said about Kura Oncology
6 statements · 5 positive · 1 negative
A major Cura breakthrough would produce substantial stock gains.
“If Cara makes a big breakthrough, you're going to see huge gains.”
Open the episode · Mad Money w/ Jim Cramer 12/19/25Listen at 22:20
Cura Oncology could suffer severe losses after failed results or setbacks.
“If it doesn't or if there are setbacks, it will be eviscerated”
Open the episode · Mad Money w/ Jim Cramer 12/19/25Listen at 22:23
Broader leukemia approval could expand Cura’s drug market to $5–$10 billion.
“Right now, this drug is approved for one type of disease. That's a $350 to $500 million end market. But if it gets approved for every type of acute leukemia, well, then you know what? That's a $5 to $10 billion market.”
Open the episode · Mad Money w/ Jim Cramer 12/19/25Listen at 26:06
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring Kura Oncology, newest first
- Nov 20, 2026
Copper miners gain leverage as smelter charges collapseTheory of Thing Investment PodcastNov 20, 2026 - Nov 16, 2026
Markets weigh leadership risk against a breakthrough cancer resultStock MoversNov 16, 2026 - Dec 19, 2025
FedEx bets transformation and AI demand can outrun the economyMad Money w/ Jim CramerDec 19, 2025